معرفی
Anna Aldovini is a researcher at Harvard University specializing in HIV molecular biology and vaccine development. She obtained her MD from the University of Padua Medical School, Italy, followed by a Fogarty Fellowship at NIH and a Research Scientist role at the Whitehead Institute.
- Institutional Affiliations: Harvard University (current), NIH (past), Whitehead Institute (past)
- Education: MD, University of Padua Medical School, Italy
Her research focuses on HIV host-pathogen interactions and mucosal vaccine development. She investigates how HIV-1 and its Tat protein modulate dendritic cell gene expression to enhance viral spread, using DNA microarray analysis and functional assays. Key findings include Tat-induced interferon-responsive genes and chemokine upregulation that recruits T cells/macrophages.
Current work evaluates mucosal DNA vaccination routes (intranasal, oral, rectal) to stimulate systemic and mucosal immunity. Her lab explores adjuvant development (e.g., Invaplex), immune activation suppression via p38 MAPK inhibitors, and vaccine-induced protection against SIV/HIV transmission.
Scientific activities include collaborations on BCG-based vaccine platforms, HIV RNA packaging mechanisms, and immune response kinetics in nonhuman primate models. Awards and honors are not explicitly mentioned in the source text.
